1

Key Investment Pockets in Companion Diagnostics and Pharma Partnerships: How 2026 Clinical Trial Integrations are Driving Value (2026–2033)

oinhu88
The minimal residual disease market size was valued at USD 2.13 billion in 2024 and is projected to reach USD 3.92 billion by 2032, with a CAGR of 7.90% during the forecast period of 2025 to 2032. https://www.databridgemarketresearch.com/reports/global-minimal-residual-disease-market
Report this page

Comments

    HTML is allowed

Who Upvoted this Story